Enter the German market without building a subsidiary.
The only plug-and-play route into German hospitals for foreign medical device manufacturers: a German entity, MDR compliance, marketing, hospital sales through a company you own, warehousing via DSW Logistik and digital visibility — under one contract. Since 1999.
Relationships built over 27 years of selling into German hospitals — university hospitals, private groups such as Asklepios, municipal hospitals and specialist clinics.
In the German hospital market — since 1999.
Twenty times the next-best European market — 2005.
- EU MDR 2017/745 compliant
- BfArM registration & EUDAMED
- Field sales with hospital experience
- GDP-compliant logistics & warehousing
Seven modules. One contract. One point of contact.
Instead of coordinating seven suppliers, you receive the complete infrastructure for entering the German market from MEX — operated by us, regulatory sound, clinically anchored and visible where German hospitals research.
German entity & management
Incorporating or acquiring a German GmbH, German bank accounts, ongoing bookkeeping, day-to-day management.
MDR compliance & regulatory affairs
EU authorised representative, PRRC, technical documentation, UDI/EUDAMED, vigilance — the full MDR pipeline behind a German hospital listing.
Marketing
Adapting your brand for Germany, hospital materials, MEDICA, trade PR — with every advertising claim reviewed in-house against MDR and HWG.
Hospital sales & listings
A hospital field team inside your own German company — listings, KOL training, DRG reimbursement argumentation, run by MEX on an interim mandate.
Logistics (DSW)
DSW Logistik GmbH handles warehousing, cold chain, sterile shipping and hospital distribution — exclusively for MEX clients.
Board of Experts
A KOL network of heads of department, nursing directors, hospital purchasers and biomedical engineers — the structural difference to any distributor.
Digital Authority
AEO/GEO, German-language SEO, LinkedIn ABM across DACH, thought leadership and pre-MEDICA campaigns — visibility that reaches hospital procurement.
From a KOL trial in Göttingen to the top EU market — in 36 months.
A US manufacturer of a bowel management system that needed explaining asked MEX to open the German market. The result: clinical validation at Göttingen University Hospital, roll-out through the MEX sales network, twenty times the volume of the next-best European market — and a sale to Hollister in 2008.
The lesson: one clinical trial at the right university hospital beats a hundred conversations with distributors.
Göttingen University Hospital — the fifth-largest hospital in Germany.
Twenty times the next-best European market — 2005.
Strategic trade sale to Hollister, Inc.
Manufacturers currently in MDR pipeline management at MEX.
- Zassi · Hollister
- Ekos Corp.
- Rüsch
- NanoVibronix
- GMP mbH
Why MEX rather than a distributor, a subsidiary or a marketing agency.
Every route into the German hospital market has its own logic. The table below shows where MEX is structurally different — and why the plug-and-play solution is the most predictable option for manufacturers who want to delegate German market entry in full.
| Kriterium | Classic distributor | Own subsidiary | Online marketing agency | MEX plug-and-play |
|---|---|---|---|---|
| Time to market | 3–6 months | 18–36 months | 3–6 months of setup | 8 weeks |
| Initial investment | Commission-based | EUR 500k – 1.5m | Retainer plus ad spend | Predictable and plannable |
| MDR compliance | Left to the manufacturer | Requires your own staff | Not part of the model | Fully integrated |
| Building clinical KOL support | Not part of the model | Has to be built | Not part of the model | Board of Experts included |
| Hospital listings | Varies by distributor | Has to be built | Not part of the model | An existing hospital network, contributed into your German entity |
| Logistics and fulfilment | Manufacturer’s responsibility | Has to be built | Not part of the model | DSW Logistik included |
| Digital authority (SEO/AEO/LinkedIn) | Not part of the model | Has to be built separately | Clicks with no link to sales | Module 7 included |
| Advertising compliance (HWG, MDR Art. 7) | Varies | Your own responsibility | High risk of unlawful claims | In-house MDR review |
| Exposure if the market does not work out | Low | A large upfront investment you cannot recover | Low | A clean exit is possible |
Ready for a market entry roadmap you can budget against?
Thirty minutes with our management — Jörg Saborowski (founder, market entry strategy) or Julian Raab (digital authority). Confidential. No charge. No obligation.